Karachi, Highnoon Laboratories Ltd NC, a leading firm in the pharmaceutical sector, reported an outstanding EPS of Rs. 47.48 for the period from January to November 2023. The stock achieved a high of Rs. 575 and a rate of Rs. 464.04, with a turnover of 6,239,200 shares. Highnoon Laboratories, with a paid-up capital of Rs. 529.83 million and listed since 1995, declared distributions of 200%10%B and 200%10%B for 2021 and 2022, respectively.
Check Also
Pakistan Emphasizes Diplomacy for Iran Nuclear Issue
Islamabad: Pakistan has reiterated that the Iran nuclear issue should be addressed through peaceful means. The remarks were made by Pakistan's Permanent Representative to the UN, Asim Iftikhar Ahmad, while speaking on the Security Council Vote on the ...
AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service